Evoke Pharma Inc
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California. Show More...
-
Website https://www.evokepharma.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 3.55 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -2.12 -1.79 -1.2 -2.2 -1.87 -1.15 -0.9 -0.46 -0.32 -0.28 Dividends USD Payout Ratio % * Shares Mil 1.0 1.0 2.0 6.0 6.0 9.0 15.0 17.0 22.0 24.0 Book Value Per Share * USD 3.15 1.91 0.73 0.38 0.13 0.31 0.21 0.12 Free Cash Flow Per Share * USD -0.5 -1.8 -1.7 -1.22 -0.52 -0.53 -0.28 Return on Assets % -265.23 -395.07 -22.6 -65.76 -97.62 -114.18 -141.91 -111.25 -118.22 -154.45 Financial Leverage (Average) 1.18 1.67 2.75 2.45 3.66 1.4 1.46 1.59 Return on Equity % -372.26 -87.24 -191.59 -296.41 -410.84 -244.42 -169.54 -231.8 Return on Invested Capital % -77.79 -69.73 -113.15 -296.41 -410.84 -244.91 -164.79 -224.9 Interest Coverage -835.09 -82.92 -16.74 -121.85 Current Ratio 2.71 0.2 10.69 8.15 5.19 6.58 3.82 3.46 3.1 2.64 Quick Ratio 2.59 0.2 10.59 7.56 4.74 6.38 3.7 3.25 2.81 2.41 Debt/Equity 0.07 0.46 1.22